Principal Financial Group’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Principal Financial Group’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-10,976	Closed	-$510K	–	2495
2023 Q2	$510K	Buy	10,976 +329	+3%	+$11.4K	﹤0.01%	1948
2023 Q1	$305K	Buy	10,647 +1,328	+14%	+$39.3K	﹤0.01%	2083
2022 Q4	$291K	Buy	+9,319	New	+$304K	﹤0.01%	2105

Principal Financial Group's DICE Position: Q3 2023 in Review

Principal Financial Group sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 10,976 shares — an estimated $510K sold.

Principal Financial Group first reported a position in DICE in Q4 2022 and held it in 3 quarters. The position peaked at $510K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Principal Financial Group reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Principal Financial Group sold 10,976 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $510K.
Principal Financial Group first reported a position in DICE Therapeutics, Inc. Common Stock in Q4 2022 and held it in 3 quarters.
Principal Financial Group's DICE Therapeutics, Inc. Common Stock position peaked at $510K in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Principal Financial Group's 13F filing for Q3 2023, filed 2 Nov 2023.